- Trials with a EudraCT protocol (24)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
24 result(s) found for: Lupus Anticoagulant.
Displaying page 1 of 2.
EudraCT Number: 2022-003137-19 | Sponsor Protocol Number: M-2022-398 | Start Date*: 2023-05-30 | |||||||||||
Sponsor Name:Miltenyi Biomedicine GmbH | |||||||||||||
Full Title: An open-label phase I/IIa, multicenter, interventional single-arm trial of MB-CART19.1 in patients with refractory SLE | |||||||||||||
Medical condition: Adult patients with refractory active systemic lupus erythematosus (SLE) with organ involvement | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000488-17 | Sponsor Protocol Number: LUPIL-2 | Start Date*: 2016-08-08 | |||||||||||
Sponsor Name:ILTOO PHARMA | |||||||||||||
Full Title: A Phase II, multi-centre, randomized, double blind, placebo-controlled study to evaluate the efficacy, safety and pharmacokinetics of ILT-101 in patients with active moderate to severe systemic lup... | |||||||||||||
Medical condition: Systematic Lupus Erythematosus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) PT (Completed) ES (Completed) BG (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000391-28 | Sponsor Protocol Number: 951404713 | Start Date*: 2017-09-20 | |||||||||||
Sponsor Name:INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON | |||||||||||||
Full Title: A PHASE II, DOUBLE-BLIND, CONTROLLED, PARALLEL-ARM TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INFUSION OF ALLOGENIC MESENCHYMAL STEM CELLS IN LUPUS NEPHRITIS (LN) | |||||||||||||
Medical condition: LUPUS NEPHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001377-28 | Sponsor Protocol Number: 27577 | Start Date*: 2008-06-11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Merck Serono International S.A. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Phase IV, one-day, single blood sampling study to investigate severe thrombocytopenia and autoimmune diseases in psoriasis subjects previously treated with RAPTIVA® (efalizumab) in the framework of... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Adult patients with moderate to severe chronic plaque psoriasis -- who have failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosp... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FR (Completed) DE (Prematurely Ended) AT (Prematurely Ended) NL (Prematurely Ended) PT (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001177-78 | Sponsor Protocol Number: APHP191008 | Start Date*: 2021-02-25 | |||||||||||||||||||||
Sponsor Name:University of Utah | |||||||||||||||||||||||
Full Title: Certolizumab to Prevent Pregnancy Complications in High-Risk Patients with APS or SLE | |||||||||||||||||||||||
Medical condition: Pregnant women with Antiphospholipid Syndrom (APS) and Lupus Antocoagulant (LAC) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002345-38 | Sponsor Protocol Number: 12/0033/CTU/IMM/001 | Start Date*: 2012-10-30 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: A prospective randomised controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. | |||||||||||||
Medical condition: Patients with antiphospholipid syndrome (APS), with or without systemic lupus erythematosus (SLE). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001802-30 | Sponsor Protocol Number: TMP-3001-2020-30 | Start Date*: 2021-10-28 |
Sponsor Name:Fraunhofer Institut für Translationale Medizin und Pharmakologie (ITMP) | ||
Full Title: Efficacy of belimumab to improve subclinical cardiovascular abnormalities using imaging endpoints with cardiac magnetic resonance in patients with systemic lupus erythematosus (BeCarma) | ||
Medical condition: Efficacy of belimumab to improve subclinical cardiovascular abnormalities using imaging endpoints with cardiac magnetic resonance in patients with systemic lupus erythematosus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001735-49 | Sponsor Protocol Number: CTU/2015/174 | Start Date*: 2019-07-01 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: Rivaroxaban versus warfarin for stroke patients with antiphospholipid syndrome, with or without SLE (RISAPS): a randomised, controlled, open-label, phase II/III, non-inferiority trial | |||||||||||||
Medical condition: Patients with stroke or other ischaemic brain injury who have antiphospholipid syndrome (APS), with or without systemic lupus erythematosus (SLE) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002256-25 | Sponsor Protocol Number: HYPATIA | Start Date*: 2018-03-09 | |||||||||||
Sponsor Name:Guy's and St Thomas' NHS Foundation Trust | |||||||||||||
Full Title: HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibodies | |||||||||||||
Medical condition: Pregnant women with antiphospholipid antibodies | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003588-73 | Sponsor Protocol Number: ALXN1007-APS-201 | Start Date*: 2014-07-28 | |||||||||||
Sponsor Name:Alexion Pharmaceuticals Inc. | |||||||||||||
Full Title: AN OPEN-LABEL PROOF OF CONCEPT PHASE IIA TRIAL OF ALXN1007 FOR THE TREATMENT OF NON-CRITERIA MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME | |||||||||||||
Medical condition: Persistently aPL-positive patients with at least 1 of the following non-criteria manifestations: aPL-nephropathy, skin ulcers and/or thrombocytopenia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004568-25 | Sponsor Protocol Number: BLAST | Start Date*: 2021-08-18 | |||||||||||
Sponsor Name:DIPARTIMENTO DI SCIENZE CLINICHE E BIOLOGICHE (UNITO) | |||||||||||||
Full Title: Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of Antiphospholipid Syndrome. | |||||||||||||
Medical condition: APS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004866-86 | Sponsor Protocol Number: P160944J | Start Date*: 2020-01-23 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Evaluation of the benefit of adjuvant treatment with hydroxychloroquine to usual medical care for uncomplicated term pregnancy in patients with primary obstetrical antiphospholipid syndrome: random... | |||||||||||||
Medical condition: Primary obstetrical antiphospholipid syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002182-38 | Sponsor Protocol Number: 2015/074/HP | Start Date*: 2015-09-28 | |||||||||||
Sponsor Name:CHU - Hôpitaux de Rouen | |||||||||||||
Full Title: Study of the Plaquenil® efficacy on the endothelial dysfunction and its vascular consequences during the antiphospholipid syndrom | |||||||||||||
Medical condition: Patients must meet the classification criteria for arterial antiphospholipids syndrom. They must have had a confirmed episode of arterial thrombosis and the presence of 2 tests performed at 12 week... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000284-21 | Sponsor Protocol Number: 524E-CVD-9101-004 | Start Date*: 2007-11-08 | |||||||||||
Sponsor Name:York Hospitals NHS Foundation Trust [...] | |||||||||||||
Full Title: A multicentre, multinational randomised control trial of prophylactic low molecular weight heparin(LMWH) in high risk pregnant thrombophilic women | |||||||||||||
Medical condition: Thrombophilia in pregnancy. This is a multi-centre, multi-national randomised controlled trial of Low Molecular Weight Heparin to prevent pregnancy complications in high-risk pregnant thrombophi... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000511-40 | Sponsor Protocol Number: ANRS_VRI04_(DALIA_2) | Start Date*: 2020-02-18 | |||||||||||
Sponsor Name:Inserm-ANRS | |||||||||||||
Full Title: Phase II, randomized, multicentric, clinical trial of a therapeutic vaccination, with ex vivo generated autologous Dentritic Cells pulsed with HIV lipopetides, combined or not with a TLR-3 agonist ... | |||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV) Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001726-22 | Sponsor Protocol Number: COLIGROW | Start Date*: 2022-12-12 | |||||||||||
Sponsor Name:Dr. Ignacio Herraiz García | |||||||||||||
Full Title: COok's ballon versus dinoprostone for Labor Induction of term pregnancies with fetal GROWth restriction (COLIGROW study). | |||||||||||||
Medical condition: Induction of term pregnancies with fetal growth restriction. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005392-39 | Sponsor Protocol Number: 213357 | Start Date*: 2022-02-25 | ||||||||||||||||
Sponsor Name:GlaxoSmithKline, S.A. | ||||||||||||||||||
Full Title: OPAL Master Protocol: A Phase 1B/2 Multicohort Umbrella Study to Evaluate the Safety and Efficacy of Novel Treatments and/or Combinations of Treatments in Participants with Ovarian Cancer (OPAL). C... | ||||||||||||||||||
Medical condition: Ovarian cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: ES (Ongoing) DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002478-11 | Sponsor Protocol Number: 2.0 | Start Date*: 2016-07-19 | |||||||||||||||||||||
Sponsor Name:Medical University of Vienna, Department of Internal medicine I | |||||||||||||||||||||||
Full Title: Very low doses of Rituximab for off-label treatment – a Pilot Trial | |||||||||||||||||||||||
Medical condition: Autoimmune-haemolytic Anemia Antiphospholipid Syndrome Immune-mediated Thrombocytopenia | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-019764-36 | Sponsor Protocol Number: SAP-02 | Start Date*: 2011-02-03 | |||||||||||
Sponsor Name:JOSEP ORDI-ROS | |||||||||||||
Full Title: RIVAROXABAN VERSUS ACENOCUMAROL EN LA PROFILAXIS SECUNDARIA DEL SÍNDROME ANTIFOSFOLÍPIDO:UN ESTUDIO MULTICÉNTRICO, PROSPECTIVO Y RANDOMIZADO. | |||||||||||||
Medical condition: Sindrome Antifosfolípido | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005273-20 | Sponsor Protocol Number: FIL-GALILEO | Start Date*: 2016-02-11 | |||||||||||
Sponsor Name:FONDAZIONE ITALIANA LINFOMI ONLUS | |||||||||||||
Full Title: Multicenter phase II single arm open-label study on the feasibility, safety and efficacy of combination of CHOP-21 supplemented with Obinutuzumab and Ibrutinib in untreated young high risk Diffus... | |||||||||||||
Medical condition: Diffuse Large B-Cell lymphoma (DLBCL) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.